Effects of Epoetin Alfa on Cognitive Function, Mood, Asthenia, and Quality of Life in Women with Breast Cancer Undergoing Adjuvant Chemotherapy
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3, S116-S120
- https://doi.org/10.3816/cbc.2002.s.022
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Novel Approaches to Preventing Chemotherapy-Induced Cognitive Dysfunction in Breast Cancer: The Art of the PossibleClinical Breast Cancer, 2002
- Revision of the American Joint Committee on Cancer Staging System for Breast CancerJournal of Clinical Oncology, 2002
- Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and LymphomaJournal of Clinical Oncology, 2002
- Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's diseaseJournal of Alzheimer's Disease, 2001
- Dose Dependent Changes in Cognitive Performance and Mood following Acute Administration ofGinsengto Healthy Young VolunteersNutritional Neuroscience, 2001
- Growth hormone, insulin-like growthfactor I and cognitive function in adultsGrowth Hormone & IGF Research, 2000
- Estrogen Therapy in Postmenopausal WomenJAMA, 1998
- Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal deathNeuroscience, 1996
- Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in micePhysiology & Behavior, 1996
- Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal womenPsychoneuroendocrinology, 1988